Figure 1. ANXA1-based survival curves, univariate and multivariate Cox regression analysis. (A) The results of Kaplan–Meier survival analysis based on the GSE17679 dataset suggested that patients in the ANXA1 low expression group had worse OS times than those in the low expression group (P<0.001). (B) The results of Kaplan–Meier survival analysis based on the GSE63157 dataset suggested that patients in the ANXA1 low expression group also had worse OS time, which was consistent with the training set (P=0.001). (C) Univariate Cox regression analysis for ANXA1 in the GSE17679 dataset (P<0.001). (D) Multivariate Cox regression analysis for ANXA1 in the GSE17679 dataset (P<0.001). (E) Univariate Cox regression analysis for ANXA1 in the GSE63157 dataset (P<0.001). (F) Multivariate Cox regression analysis for ANXA1 in the GSE63157 dataset (P<0.001).